Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biomarkers of Hypoglycaemia in Type 2 Diabetes
NCT03102801Completed
- Sponsor
- University of Hull
- Start
- Mar 2017
- Primary completion
- Jan 2018
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by University of Hull. Primary endpoint: Composite number of endothelial microparticles (CD105, CD106, CD142, CD54, CD62 & CD31). Started Mar 2017; status: completed.
Beyond the preview
Go deeper on NCT03102801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03102801.